Cite
Yellapantula V, Hultcrantz M, Rustad EH, et al. Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma. Blood Cancer J. 2019;9(12):101doi: 10.1038/s41408-019-0264-y.
Yellapantula, V., Hultcrantz, M., Rustad, E. H., Wasserman, E., Londono, D., Cimera, R., Ciardiello, A., Landau, H., Akhlaghi, T., Mailankody, S., Patel, M., Medina-Martinez, J. S., Arango Ossa, J. E., Levine, M. F., Bolli, N., Maura, F., Dogan, A., Papaemmanuil, E., Zhang, Y., & Landgren, O. (2019). Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma. Blood cancer journal, 9(12), 101. https://doi.org/10.1038/s41408-019-0264-y
Yellapantula, Venkata, et al. "Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma." Blood cancer journal vol. 9,12 (2019): 101. doi: https://doi.org/10.1038/s41408-019-0264-y
Yellapantula V, Hultcrantz M, Rustad EH, Wasserman E, Londono D, Cimera R, Ciardiello A, Landau H, Akhlaghi T, Mailankody S, Patel M, Medina-Martinez JS, Arango Ossa JE, Levine MF, Bolli N, Maura F, Dogan A, Papaemmanuil E, Zhang Y, Landgren O. Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma. Blood Cancer J. 2019 Dec 11;9(12):101. doi: 10.1038/s41408-019-0264-y. PMID: 31827071; PMCID: PMC6906304.
Copy
Download .nbib